Generic drug stocks bounce, but analysts warn not to jump in

Shares of generic drugmakers bounced, following what some analysts called an excessive selloff in the previous session, but those same analysts didn’t recommended using the weakness to buy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.